市場調査レポート

商品コード

1405836

制吐薬の市場規模、シェア、動向分析レポート：薬剤タイプ別、最終用途別、地域別、セグメント別予測、2024年～2030年

Antiemetics Drugs Market Size, Share & Trends Analysis Report By Drug Type (Serotonin-receptor Antagonists, Dopamine Receptor Antagonists), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

出版日: 2023年12月11日 | 発行: Grand View Research

| ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

Unprintable PDF (Single User License)

USD 5,950 932,722円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストはできません。PDFの印刷もできません。

Printable PDF (5-User License)

USD 6,950 1,089,482円

レポートPDFを同一企業内の同一部署における5名様までの方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

Printable PDF (Enterprise License)

USD 8,950 1,403,002円

レポートPDFの購入企業、およびその子会社、関連会社の方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

制吐薬市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、制吐薬の世界市場規模は2024年から2030年にかけて5.98%のCAGRを示し、2030年までに112億米ドルに達する見込みです。

吐き気と嘔吐を引き起こす様々な疾患の有病率の増加と相まって、主要企業の戦略的イニシアチブの増加などの要因が、市場の需要を前進させています。

主要な業界プレイヤーの活動の高まりは、制吐薬の需要を強化する主な要因の1つです。市場参入企業は、制吐薬市場における地位を強化するために、提携、買収、新製品の発売、製品の承認、事業拡大など、さまざまな取り組みを行っています。例えば、2020年5月、米国食品医薬品局は、化学療法によって誘発される吐き気と嘔吐の予防を目的としたヘルシン・グループのAKYNZEO注射剤を承認しました。このように、新規製品の承認の増加は、今後数年間の業界の成長を促進すると予想されます。

化学療法や術後の悪心・嘔吐（PONV）といった主な適応症に加え、食中毒や飲酒といった他の症状も、予測期間中、これらの医薬品の需要を牽引しています。NCBIが2021年11月に発表した論文によると、サブサリチル酸ビスマスなどの特定の市販の制吐薬は、食中毒に伴う吐き気や嘔吐に有効であることが示唆されています。

さらに、2022年10月にFrontiers誌に掲載された研究では、セロトニン受容体拮抗薬であるオンダンセトロンが、早期発症アルコール依存症（EOA）患者におけるアルコール使用障害に有効な治療薬であることが報告されました。その結果、アルコール消費量の増加や食中毒の発生を受けて、制吐薬の需要が高まると予想されます。

制吐薬市場のレポートハイライト

薬剤タイプ別では、セロトニン受容体拮抗薬が2023年に29.71%で市場を独占し、この優位性は、がん患者の増加とセロトニン受容体拮抗薬の使用増加によるものと考えられます。
用途別では、化学療法に伴う悪心・嘔吐をターゲットにした製品の発売が増加していることから、化学療法分野が2023年に45.70%のシェアで市場最大の収益貢献者でした。
最終用途セグメントでは、小売薬局セグメントが2023年に47.91%の収益シェアで市場を独占しました。対照的に、その他のセグメントは予測期間中に最も速い成長を記録すると予測されています。
北米地域は、Pfizer、Merck Co &Inc、GSK plcのような大手企業の存在により、2023年に36.52%のシェアで市場を独占しました。一方、アジア太平洋地域は予測期間中に最も速い成長を示すと予想されています。

地域別制吐薬市場シェア、2023年および2030年
北米
- 北米の制吐薬市場、2018年から2030年
- 米国
- カナダ
欧州
- 欧州の制吐薬市場、2018年から2030年
- 英国
- ドイツ
- フランス
- イタリア
- スペイン
- デンマーク
- スウェーデン
- ノルウェー
アジア太平洋地域
- アジア太平洋地域の制吐薬市場、2018～2030年
- 日本
- 中国
- インド
- オーストラリア
- タイ
- 韓国
ラテンアメリカ
- ラテンアメリカの制吐薬市場、2018年から2030年
- ブラジル
- メキシコ
- アルゼンチン
中東・アフリカ
- MEA制吐薬市場、2018年～2030年
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- クウェート

第8章競合情勢

企業の分類
戦略マッピング
企業の市場シェア分析、2023年
企業プロファイル・一覧表
- Pfizer Inc.
- Cipla Inc.
- Merck KGaA
- Eagle Pharmaceuticals, Inc.
- Johnson &Johnson Services, Inc.
- GSK plc.
- Astellas Pharma Inc.
- GLENMARK PHARMACEUTICALS LTD.
- Viatris Inc.
- Baxter

図表

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
Table 4 Global Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
Table 5 Global Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
Table 6 Global Antiemetics Drugs Market, By Region, 2018 - 2030 (USD Million)
Table 7 North America Antiemetics Drugs Market, By Country, 2018 - 2030 (USD Million)
Table 8 North America Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
Table 9 North America Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
Table 10 North America Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
Table 11 U.S. Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
Table 12 U.S. Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
Table 13 U.S. Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
Table 14 Canada Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
Table 15 Canada Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
Table 16 Canada Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
Table 17 Europe Antiemetics Drugs Market, By Country, 2018 - 2030 (USD Million)
Table 18 Europe Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
Table 19 Europe Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
Table 20 Europe Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
Table 21 UK Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
Table 22 UK Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
Table 23 UK Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
Table 24 Germany Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
Table 25 Germany Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
Table 26 Germany Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
Table 27 France Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
Table 28 France Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
Table 29 France Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
Table 30 Spain Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
Table 31 Spain Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
Table 32 Spain Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
Table 33 Italy Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
Table 34 Italy Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
Table 35 Italy Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
Table 36 Denmark Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
Table 37 Denmark Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
Table 38 Denmark Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
Table 39 Norway Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
Table 40 Norway Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
Table 41 Norway Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
Table 42 Sweden Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
Table 43 Sweden Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
Table 44 Sweden Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
Table 45 Asia Pacific Antiemetics Drugs Market, By Country, 2018 - 2030 (USD Million)
Table 46 Asia Pacific Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
Table 49 China Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
Table 50 China Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
Table 51 China Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
Table 52 Japan Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
Table 53 Japan Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
Table 54 Japan Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
Table 55 India Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
Table 56 India Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
Table 57 India Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
Table 58 South Korea Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
Table 59 South Korea Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
Table 60 South Korea Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
Table 61 Australia Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
Table 62 Australia Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
Table 63 Australia Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
Table 64 Thailand Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
Table 65 Thailand Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
Table 66 Thailand Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
Table 67 Latin America Antiemetics Drugs Market, By Country, 2018 - 2030 (USD Million)
Table 68 Latin America Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
Table 69 Latin America Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
Table 70 Latin America Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
Table 71 Brazil Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
Table 72 Brazil Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
Table 73 Brazil Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
Table 74 Mexico Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
Table 75 Mexico Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
Table 76 Mexico Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
Table 77 Argentina Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million),
Table 78 Argentina Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
Table 79 Argentina Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
Table 80 MEA Antiemetics Drugs Market, By Country, 2018 - 2030 (USD Million)
Table 81 MEA Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
Table 82 MEA Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
Table 83 MEA Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
Table 84 South Africa Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
Table 85 South Africa Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
Table 86 South Africa Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
Table 87 UAE Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
Table 88 UAE Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
Table 89 UAE Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
Table 90 Saudi Arabia Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million),
Table 91 Saudi Arabia Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
Table 92 Saudi Arabia Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
Table 93 Kuwait Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
Table 94 Kuwait Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
Table 95 Kuwait Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Antiemetics drugs market segmentation
Fig. 8 Market snapshot, 2023
Fig. 9 Market Trends & outlook
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Market restraint relevance analysis (Current & future impact)
Fig. 12 PESTEL analysis
Fig. 13 Porter's Five Forces analysis
Fig. 14 Global antiemetics drugs market: Drug type outlook and key takeaways
Fig. 15 Global antiemetics drugs market: Drug type movement analysis
Fig. 16 Global antiemetics drugs market, for serotonin-receptor antagonists, 2018 - 2030 (USD Million)
Fig. 17 Global antiemetics drugs market, for anticholinergics, 2018 - 2030 (USD Million)
Fig. 18 Global antiemetics drugs market, for dopamine receptor antagonists, 2018 - 2030 (USD Million)
Fig. 19 Global antiemetics drugs market, for neurokinin receptor antagonists, 2018 - 2030 (USD Million)
Fig. 20 Global antiemetics drugs market, for other drug types, 2018 - 2030 (USD Million)
Fig. 21 Global antiemetics drugs market: Application outlook and key takeaways
Fig. 22 Global antiemetics drugs market: Application movement analysis
Fig. 23 Global antiemetics drugs market, for chemotherapy, 2018 - 2030 (USD Million)
Fig. 24 Global antiemetics drugs market, for gastroenteritis, 2018 - 2030 (USD Million)
Fig. 25 Global antiemetics drugs market, for post-operative surgery, 2018 - 2030 (USD Million)
Fig. 26 Global antiemetics drugs market, for others, 2018 - 2030 (USD Million)
Fig. 27 Global antiemetics drugs market: End-use outlook and key takeaways
Fig. 28 Global antiemetics drugs market: End-use movement analysis
Fig. 29 Global antiemetics drugs market, for hospital & clinics, 2018 - 2030 (USD Million)
Fig. 30 Global antiemetics drugs market, for retail pharmacy, 2018 - 2030 (USD Million)
Fig. 31 Global antiemetics drugs market, for others, 2018 - 2030 (USD Million)
Fig. 32 Regional marketplace: Key takeaways
Fig. 33 Regional outlook, 2023 & 2030
Fig. 34 Global antiemetics drugs market: Region movement analysis
Fig. 35 North America antiemetics drugs market, 2018 - 2030 (USD Million)
Fig. 36 US antiemetics drugs market, 2018 - 2030 (USD Million)
Fig. 37 Canada antiemetics drugs market, 2018 - 2030 (USD Million)
Fig. 38 Europe antiemetics drugs market, 2018 - 2030 (USD Million)
Fig. 39 Germany antiemetics drugs market, 2018 - 2030 (USD Million)
Fig. 40 UK antiemetics drugs market, 2018 - 2030 (USD Million)
Fig. 41 France antiemetics drugs market, 2018 - 2030 (USD Million)
Fig. 42 Italy antiemetics drugs market, 2018 - 2030 (USD Million)
Fig. 43 Spain antiemetics drugs market, 2018 - 2030 (USD Million)
Fig. 44 Denmark antiemetics drugs market, 2018 - 2030 (USD Million)
Fig. 45 Sweden antiemetics drugs market, 2018 - 2030 (USD Million)
Fig. 46 Norway antiemetics drugs market, 2018 - 2030 (USD Million)
Fig. 47 Asia Pacific antiemetics drugs market, 2018 - 2030 (USD Million)
Fig. 48 Japan antiemetics drugs market, 2018 - 2030 (USD Million)
Fig. 49 China antiemetics drugs market, 2018 - 2030 (USD Million)
Fig. 50 India antiemetics drugs market, 2018 - 2030 (USD Million)
Fig. 51 Australia antiemetics drugs market, 2018 - 2030 (USD Million)
Fig. 52 South Korea antiemetics drugs market, 2018 - 2030 (USD Million)
Fig. 53 Thailand antiemetics drugs market, 2018 - 2030 (USD Million)
Fig. 54 Latin America antiemetics drugs market, 2018 - 2030 (USD Million)
Fig. 55 Brazil antiemetics drugs market, 2018 - 2030 (USD Million)
Fig. 56 Mexico antiemetics drugs market, 2018 - 2030 (USD Million)
Fig. 57 Argentina antiemetics drugs market, 2018 - 2030 (USD Million)
Fig. 58 Middle East and Africa antiemetics drugs market, 2018 - 2030 (USD Million)
Fig. 59 South Africa antiemetics drugs market, 2018 - 2030 (USD Million)
Fig. 60 Saudi Arabia antiemetics drugs market, 2018 - 2030 (USD Million)
Fig. 61 UAE antiemetics drugs market, 2018 - 2030 (USD Million)
Fig. 62 Kuwait antiemetics drugs market, 2018 - 2030 (USD Million)

Product Code: GVR-4-68040-165-9

Antiemetics Drugs Market Growth & Trends:

The global antiemetics drugs market size is expected to reach USD 11.20 billion by 2030, exhibiting a CAGR of 5.98% from 2024 to 2030, according to a new report by Grand View Research, Inc. Factors such as the increasing strategic initiatives of the key players coupled with the increasing prevalence of various diseases causing nausea and vomiting are propelling market demand forward.

The rising activity of major industry players is one of the major factors bolstering the demand for antiemetics drugs. Industry participants are undertaking various initiatives such as partnerships, acquisitions, new product launches, product approvals, and expansions to strengthen their position in the antiemetics drugs market. For instance, in May 2020, the U.S. Food and Drug Administration approved an AKYNZEO injection from the Helsinn Group for the prevention of nausea and vomiting induced by chemotherapy. Thus, increasing novel product approvals are anticipated to drive industry growth in the coming years.

In addition to key indications such as chemotherapy and postoperative nausea and vomiting (PONV), other conditions such as food poisoning and alcohol consumption are also driving the demand for these medicines over the forecast period. An article published by NCBI in November 2021 suggests that certain over-the-counter antiemetics, such as Bismuth Subsalicylate, are effective in addressing nausea and vomiting associated with food poisoning.

Moreover, a study published in Frontiers in October 2022 reported that ondansetron, a serotonin receptor antagonist, is an effective treatment for alcohol use disorder in patients with early onset alcoholism (EOA). Consequently, the demand for antiemetic medicines is expected to rise in response to increased alcohol consumption and incidents of food poisoning.

Antiemetics Drugs Market Report Highlights:

On the basis of drug type, the serotonin-receptor antagonists segment dominated the market at 29.71% in 2023 and this dominance can be attributed to the rising cases of cancer coupled with the increasing use of serotonin-receptor antagonist drugs.
Based on the application, the chemotherapy segment was the largest revenue contributor to the market with a share of 45.70% in 2023 owing to the increasing product launches targeting nausea and vomiting associated with chemotherapy.
In the end-use segment, the retail pharmacy segment dominated the market with a revenue share of 47.91% in 2023. In contrast, the other segment is anticipated to register the fastest growth over the forecast period.
The North America region dominated the market with a share of 36.52% in 2023 owing to the presence of major players like Pfizer, Merck Co & Inc, and GSK plc. On the other hand, Asia Pacific is expected to showcase the fastest growth over the forecast period.

Chapter 1. Methodology and Scope

1.1. Segment Definitions
- 1.1.1. Drug Type Segment
- 1.1.2. Application Segment
- 1.1.3. End-use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
- 1.4.1. Objective - 1
- 1.4.2. Objective - 2
- 1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
- 1.6.1. Purchased Database
- 1.6.2. GVR's Internal Database
- 1.6.3. Secondary Sources
- 1.6.4. Primary Research
1.7. Information or Data Analysis
- 1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
- 1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
1.12. Research Assumptions

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. Increasing Prevalence of Target Diseases
  - 3.2.1.2. Rising Investments by Industry Participants in R&D Activities
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. Adverse Effects Associated with Anti emetics Drugs
3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis

Chapter 4. Drug Type Business Analysis

4.1. Antiemetics Drugs Market: Drug Type Movement Analysis
4.2. Serotonin-Receptor Antagonists
- 4.2.1. Serotonin-Receptor Antagonists Market, 2018 - 2030 (USD Million)
4.3. Anticholinergics
- 4.3.1. Anticholinergics Market, 2018 - 2030 (USD Million)
4.4. Dopamine Receptor Antagonists
- 4.4.1. Dopamine Receptor Antagonists Market, 2018 - 2030 (USD Million)
4.5. Neurokinin Receptor Antagonists
- 4.5.1. Neurokinin Receptor Antagonists Market, 2018 - 2030 (USD Million)
4.6. Others
- 4.6.1. Other Drug Types Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

5.1. Antiemetics Drugs Market: Application Movement Analysis
5.2. Chemotherapy
- 5.2.1. Chemotherapy Market, 2018 - 2030 (USD Million)
5.3. Gastroenteritis
- 5.3.1. Gastroenteritis Market, 2018 - 2030 (USD Million)
5.4. Post-Operative Surgery
- 5.4.1. Post Operative Surgery Market, 2018 - 2030 (USD Million)
5.5. Others
- 5.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. End-use Business Analysis

6.1. Antiemetics Drugs Market: End-use Movement Analysis
6.2. Hospital & Clinics
- 6.2.1. Hospital & Clinics Market, 2018 - 2030 (USD Million)
6.3. Retail Pharmacy
- 6.3.1. Retail Pharmacy Market, 2018 - 2030 (USD Million)
6.4. Others
- 6.4.1. Other End-use Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

7.1. Antiemetics Drugs Market Share By Region, 2023 & 2030
7.2. North America
- 7.2.1. North America Antiemetics Drugs Market, 2018 - 2030 (USD Million)
- 7.2.2. U.S.
  - 7.2.2.1. Key Country Dynamics
  - 7.2.2.2. Competitive Scenario
  - 7.2.2.3. Regulatory Framework
  - 7.2.2.4. U.S. Antiemetics Drugs Market, 2018 - 2030 (USD Million)
- 7.2.3. Canada
  - 7.2.3.1. Key Country Dynamics
  - 7.2.3.2. Competitive Scenario
  - 7.2.3.3. Regulatory Framework
  - 7.2.3.4. Canada Antiemetics Drugs Market, 2018 - 2030 (USD Million)
7.3. Europe
- 7.3.1. Europe Antiemetics Drugs Market, 2018 - 2030 (USD Million)
- 7.3.2. UK
  - 7.3.2.1. Key Country Dynamics
  - 7.3.2.2. Competitive Scenario
  - 7.3.2.3. Regulatory Framework
  - 7.3.2.4. UK Antiemetics Drugs Market, 2018 - 2030 (USD Million)
- 7.3.3. Germany
  - 7.3.3.1. Key Country Dynamics
  - 7.3.3.2. Competitive Scenario
  - 7.3.3.3. Regulatory Framework
  - 7.3.3.4. Germany Antiemetics Drugs Market, 2018 - 2030 (USD Million)
- 7.3.4. France
  - 7.3.4.1. Key Country Dynamics
  - 7.3.4.2. Competitive Scenario
  - 7.3.4.3. Regulatory Framework
  - 7.3.4.4. France Antiemetics Drugs Market, 2018 - 2030 (USD Million)
- 7.3.5. Italy
  - 7.3.5.1. Key Country Dynamics
  - 7.3.5.2. Competitive Scenario
  - 7.3.5.3. Regulatory Framework
  - 7.3.5.4. Italy Antiemetics Drugs Market, 2018 - 2030 (USD Million)
- 7.3.6. Spain
  - 7.3.6.1. Key Country Dynamics
  - 7.3.6.2. Competitive Scenario
  - 7.3.6.3. Regulatory Framework
  - 7.3.6.4. Spain Antiemetics Drugs Market, 2018 - 2030 (USD Million)
- 7.3.7. Denmark
  - 7.3.7.1. Key Country Dynamics
  - 7.3.7.2. Competitive Scenario
  - 7.3.7.3. Regulatory Framework
  - 7.3.7.4. Denmark Antiemetics Drugs Market, 2018 - 2030 (USD Million)
- 7.3.8. Sweden
  - 7.3.8.1. Key Country Dynamics
  - 7.3.8.2. Competitive Scenario
  - 7.3.8.3. Regulatory Framework
  - 7.3.8.4. Sweden Antiemetics Drugs Market, 2018 - 2030 (USD Million)
- 7.3.9. Norway
  - 7.3.9.1. Key Country Dynamics
  - 7.3.9.2. Competitive Scenario
  - 7.3.9.3. Regulatory Framework
  - 7.3.9.4. Norway Antiemetics Drugs Market, 2018 - 2030 (USD Million)
7.4. Asia Pacific
- 7.4.1. Asia Pacific Antiemetics Drugs Market, 2018 - 2030 (USD Million)
- 7.4.2. Japan
  - 7.4.2.1. Key Country Dynamics
  - 7.4.2.2. Competitive Scenario
  - 7.4.2.3. Regulatory Framework
  - 7.4.2.4. Japan Antiemetics Drugs Market, 2018 - 2030 (USD Million)
- 7.4.3. China
  - 7.4.3.1. Key Country Dynamics
  - 7.4.3.2. Competitive Scenario
  - 7.4.3.3. Regulatory Framework
  - 7.4.3.4. China Antiemetics Drugs Market, 2018 - 2030 (USD Million)
- 7.4.4. India
  - 7.4.4.1. Key Country Dynamics
  - 7.4.4.2. Competitive Scenario
  - 7.4.4.3. Regulatory Framework
  - 7.4.4.4. India Antiemetics Drugs Market, 2018 - 2030 (USD Million)
- 7.4.5. Australia
  - 7.4.5.1. Key Country Dynamics
  - 7.4.5.2. Competitive Scenario
  - 7.4.5.3. Regulatory Framework
  - 7.4.5.4. Australia Antiemetics Drugs Market, 2018 - 2030 (USD Million)
- 7.4.6. Thailand
  - 7.4.6.1. Key Country Dynamics
  - 7.4.6.2. Competitive Scenario
  - 7.4.6.3. Regulatory Framework
  - 7.4.6.4. Thailand Antiemetics Drugs Market, 2018 - 2030 (USD Million)
- 7.4.7. South Korea
  - 7.4.7.1. Key Country Dynamics
  - 7.4.7.2. Competitive Scenario
  - 7.4.7.3. Regulatory Framework
  - 7.4.7.4. South Korea Antiemetics Drugs Market, 2018 - 2030 (USD Million)
7.5. Latin America
- 7.5.1. Latin America Antiemetics Drugs Market, 2018 - 2030 (USD Million)
- 7.5.2. Brazil
  - 7.5.2.1. Key Country Dynamics
  - 7.5.2.2. Competitive Scenario
  - 7.5.2.3. Regulatory Framework
  - 7.5.2.4. Brazil Antiemetics Drugs Market, 2018 - 2030 (USD Million)
- 7.5.3. Mexico
  - 7.5.3.1. Key Country Dynamics
  - 7.5.3.2. Competitive Scenario
  - 7.5.3.3. Regulatory Framework
  - 7.5.3.4. Mexico Antiemetics Drugs Market, 2018 - 2030 (USD Million)
- 7.5.4. Argentina
  - 7.5.4.1. Key Country Dynamics
  - 7.5.4.2. Competitive Scenario
  - 7.5.4.3. Regulatory Framework
  - 7.5.4.4. Argentina Antiemetics Drugs Market, 2018 - 2030 (USD Million)
7.6. MEA
- 7.6.1. MEA Antiemetics Drugs Market, 2018 - 2030 (USD Million)
- 7.6.2. South Africa
  - 7.6.2.1. Key Country Dynamics
  - 7.6.2.2. Competitive Scenario
  - 7.6.2.3. Regulatory Framework
  - 7.6.2.4. South Africa Antiemetics Drugs Market, 2018 - 2030 (USD Million)
- 7.6.3. Saudi Arabia
  - 7.6.3.1. Key Country Dynamics
  - 7.6.3.2. Competitive Scenario
  - 7.6.3.3. Regulatory Framework
  - 7.6.3.4. Saudi Arabia Antiemetics Drugs Market, 2018 - 2030 (USD Million)
- 7.6.4. UAE
  - 7.6.4.1. Key Country Dynamics
  - 7.6.4.2. Competitive Scenario
  - 7.6.4.3. Regulatory Framework
  - 7.6.4.4. UAE Antiemetics Drugs Market, 2018 - 2030 (USD Million)
- 7.6.5. Kuwait
  - 7.6.5.1. Key Country Dynamics
  - 7.6.5.2. Competitive Scenario
  - 7.6.5.3. Regulatory Framework
  - 7.6.5.4. Kuwait Antiemetics Drugs Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Share Analysis, 2023
8.4. Company Profiles/Listing
- 8.4.1. Pfizer Inc.
  - 8.4.1.1. Overview
  - 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 8.4.1.3. Product Benchmarking
  - 8.4.1.4. Strategic Initiatives
- 8.4.2. Cipla Inc.
  - 8.4.2.1. Overview
  - 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 8.4.2.3. Product Benchmarking
  - 8.4.2.4. Strategic Initiatives
- 8.4.3. Merck KGaA
  - 8.4.3.1. Overview
  - 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 8.4.3.3. Product Benchmarking
  - 8.4.3.4. Strategic Initiatives
- 8.4.4. Eagle Pharmaceuticals, Inc.
  - 8.4.4.1. Overview
  - 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 8.4.4.3. Product Benchmarking
  - 8.4.4.4. Strategic Initiatives
- 8.4.5. Johnson & Johnson Services, Inc.
  - 8.4.5.1. Overview
  - 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 8.4.5.3. Product Benchmarking
  - 8.4.5.4. Strategic Initiatives
- 8.4.6. GSK plc.
  - 8.4.6.1. Overview
  - 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 8.4.6.3. Product Benchmarking
  - 8.4.6.4. Strategic Initiatives
- 8.4.7. Astellas Pharma Inc.
  - 8.4.7.1. Overview
  - 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 8.4.7.3. Product Benchmarking
  - 8.4.7.4. Strategic Initiatives
- 8.4.8. GLENMARK PHARMACEUTICALS LTD.
  - 8.4.8.1. Overview
  - 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 8.4.8.3. Product Benchmarking
  - 8.4.8.4. Strategic Initiatives
- 8.4.9. Viatris Inc.
  - 8.4.9.1. Overview
  - 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 8.4.9.3. Product Benchmarking
  - 8.4.9.4. Strategic Initiatives
- 8.4.10. Baxter
  - 8.4.10.1. Overview
  - 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 8.4.10.3. Product Benchmarking
  - 8.4.10.4. Strategic Initiatives

制吐薬の市場規模、シェア、動向分析レポート：薬剤タイプ別、最終用途別、地域別、セグメント別予測、2024年～2030年

Antiemetics Drugs Market Size, Share & Trends Analysis Report By Drug Type (Serotonin-receptor Antagonists, Dopamine Receptor Antagonists), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

制吐薬市場の成長と動向：

制吐薬市場のレポートハイライト

目次

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章市場変数、動向、および範囲

第4章薬剤タイプのビジネス分析

第5章用途のビジネス分析

第6章最終用途のビジネス分析

第7章地域のビジネス分析

第8章競合情勢

List of Tables

List of Figures

Antiemetics Drugs Market Growth & Trends:

Antiemetics Drugs Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Market Variables, Trends, & Scope

Chapter 4. Drug Type Business Analysis

Chapter 5. Application Business Analysis

Chapter 6. End-use Business Analysis

Chapter 7. Regional Business Analysis

Chapter 8. Competitive Landscape

制吐薬の市場規模、シェア、動向分析レポート：薬剤タイプ別、最終用途別、地域別、セグメント別予測、2024年～2030年

Antiemetics Drugs Market Size, Share & Trends Analysis Report By Drug Type (Serotonin-receptor Antagonists, Dopamine Receptor Antagonists), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

制吐薬市場の成長と動向：

制吐薬市場のレポートハイライト

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、および範囲

第4章 薬剤タイプのビジネス分析

第5章 用途のビジネス分析

第6章 最終用途のビジネス分析

第7章 地域のビジネス分析

第8章 競合情勢

List of Tables

List of Figures

Antiemetics Drugs Market Growth & Trends:

Antiemetics Drugs Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Market Variables, Trends, & Scope

Chapter 4. Drug Type Business Analysis

Chapter 5. Application Business Analysis

Chapter 6. End-use Business Analysis

Chapter 7. Regional Business Analysis

Chapter 8. Competitive Landscape

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章市場変数、動向、および範囲

第4章薬剤タイプのビジネス分析

第5章用途のビジネス分析

第6章最終用途のビジネス分析

第7章地域のビジネス分析

第8章競合情勢